HIPRA participated in the 48^th edition of the World Small Animal Veterinary Association (WSAVA), which took place in Lisbon at the end of September. HIPRA had a booth focused on the new campaign for our HIPRADOG® vaccine range.

This edition of the congress had the highest number of registrations in its history, increasing from 2,186 participants in the 2019 edition to a total of 3,763 attendees this year. This edition was held in Europe, which was reflected in the diversity of the participants, coming from 102 different countries, 67% of which were from European countries.

HIPRA had a booth focused on the new campaign for our HIPRADOG® vaccine range. The winning pets of the contest organized among HIPRA employees participated in this campaign, which added a special and personalized touch.

We also wanted to emphasize our commitment to the prevention of rabbit haemorrhagic disease with the presentation of the new YURVAC RHD campaign and vaccine. To raise awareness of our new vaccine, we organized an exciting quiz for the booth visitors.

HIPRA also participated in the WSAVA with the publication of a scientific paper by our colleage from HIPRA PORTUGAL, Filipe Pinto, focused on the antemortem diagnosis of rabbit haemorrhagic disease.

Once again, HIPRA reinforces its commitment to solutions for pets and reaffirms itself as a reference in prevention for a healthier world.